---
$id: https://graph.org.ai/products/commodity/51152026
$type: Product
source: UNSPSC
code: "51152026"
title: "Denpidazone"
class: "51152000"
classTitle: "Neuromuscular blocking agents"
family: "51150000"
familyTitle: "Autonomic nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Denpidazone

**UNSPSC Code**: 51152026
**Class**: [Neuromuscular blocking agents](Neuromuscular blocking agents.mdx)
**Family**: [Autonomic nervous system drugs](../Autonomic nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a muscle relaxant with the molecular formula C20H20N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier E7N3FX2T1J, chemically known as 3,6-pyridazinedione, 1,2-dihydro-4-butyl-5-hydroxy-1,2-diphenyl- but generally known as denpidazone, which bears US NIH Compound Identifier 206004. European Medicines Agency schedules Denpidazone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06979MIG. The term DENPIDAZONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 25 , No. 10 1971, List 11). DENPIDAZONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule denpidazone under HS 29339990 and SITC 51577. As of Q4 2014, DENPIDAZONE remains the US FDA Preferred Term for this commodity. Denpidazone bears US NLM identifiers UMLS ID C2699589 and NCI Concept Code C77599. SMILES: OC1N(N(C(=O)C(=O)C1CCCC)C1CCCCC1)C1CCCCC1.

